Key points Inadequate sleep and irregular work schedules have not only adverse consequences for individual health and well‐being, but also enormous economic and safety implications for society as a whole.This study demonstrates that visual motion processing and coordinated eye movements are significantly impaired when performed after sleep loss and during the biological night, and thus may be contributing to human error and accidents.Because affected individuals are often unaware of their sensorimotor and cognitive deficits, there is a critical need for non‐invasive, objective indicators of mild, yet potentially unsafe, impairment due to disrupted sleep or biological rhythms.Our findings show that a set of eye‐movement measures can be used to provide sensitive and reliable indicators of such mild neural impairments. AbstractSleep loss and circadian misalignment have long been known to impair human cognitive and motor performance with significant societal and health consequences. It is well known that human reaction time to a visual cue is impaired following sleep loss and circadian misalignment, but it has remained unclear how more complex visuomotor control behaviour is altered under these conditions. In this study, we measured 14 parameters of the voluntary ocular tracking response of 12 human participants (six females) to systematically examine the effects of sleep loss and circadian misalignment using a constant routine 24‐h acute sleep‐deprivation paradigm. The combination of state‐of‐the‐art oculometric and sleep‐research methodologies allowed us to document, for the first time, large changes in many components of pursuit, saccades and visual motion processing as a function of time awake and circadian phase. Further, we observed a pattern of impairment across our set of oculometric measures that is qualitatively different from that observed previously with other mild neural impairments. We conclude that dynamic vision and visuomotor control exhibit a distinct pattern of impairment linked with time awake and circadian phase. Therefore, a sufficiently broad set of oculometric measures could provide a sensitive and specific behavioural biomarker of acute sleep loss and circadian misalignment. We foresee potential applications of such oculometric biomarkers assisting in the assessment of readiness‐to‐perform higher risk tasks and in the characterization of sub‐clinical neural impairment in the face of a multiplicity of potential risk factors, including disrupted sleep and circadian rhythms.
PurposeWe set out to determine whether individuals with central field loss benefit from using two eyes to perform a grasping task. Specifically, we tested the hypothesis that this advantage is correlated with coarse stereopsis, in addition to binocular summation indices of visual acuity, contrast sensitivity, and binocular visual field.MethodsSixteen participants with macular degeneration and nine age-matched controls placed pegs on a pegboard, while their eye and hand movements were recorded. Importantly, the pegboard was placed near eye height, to minimize the contribution of monocular cues to peg position. All participants performed this task binocularly and monocularly. Before the experiment, we performed microperimetry to determine the profile of field loss in each eye and the locations of eccentric fixation (if applicable). In addition, we measured both acuity and contrast sensitivity monocularly and binocularly, and stereopsis by using both a RanDot test and a custom stereo test.ResultsPeg-placement time was significantly shorter and participants made significantly fewer errors with binocular than with monocular viewing in both the patient and control groups. Among participants with measurable stereopsis, binocular advantage in peg-placement time was significantly correlated with stereoacuity (ρ = −0.78; P = 0.003). In patients without measurable stereopsis, the binocular advantage was related significantly to the overlap in the scotoma between the two eyes (ρ = −0.81; P = 0.032).ConclusionsThe high correlation between grasp performance and stereoacuity indicates that coarse stereopsis may benefit tasks of daily living for individuals with central field loss.
Pupil diameter has long been used as a metric of cognitive processing. However, recent advances suggest that the cognitive sources of change in pupil size may reflect LC-NE function and the calculation of unexpected uncertainty in decision processes (Aston-Jones and Cohen, 2005; Yu and Dayan, 2005). In the current experiments, we explored the role of uncertainty in attentional selection on task-evoked changes in pupil diameter during visual search. We found that task-evoked changes in pupil diameter were related to uncertainty during attentional selection as measured by reaction time (RT) and performance accuracy (Experiments 1-2). Control analyses demonstrated that the results are unlikely to be due to error monitoring or response uncertainty. Our results suggest that pupil diameter can be used as an implicit metric of uncertainty in ongoing attentional selection requiring effortful control processes.
The current study demonstrates the dose-dependent impairment in oculomotor and ocular behaviours across a range of ultra-low BACs (<0.035%). r Processing of target speed and direction, as well as pursuit eye movements, are significantly impaired at 0.015% BAC, suggesting impaired neural activity within brain regions associated with the visual processing of motion. r Catch-up saccades during steady visual tracking of the moving target compensate for the reduced vigour of smooth eye movements that occurs with the ingestion of low-dose alcohol. r Saccade dynamics start to become 'sluggish' at as low as 0.035% BAC. r Pupillary light responses appear unaffected at BAC levels up to 0.065%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.